Interactive Hand Exercise Game on Grip Strength and Vascular Maturation (NCT05493046) | Clinical Trial Compass
CompletedNot Applicable
Interactive Hand Exercise Game on Grip Strength and Vascular Maturation
Taiwan30 participantsStarted 2022-08-10
Plain-language summary
Hemodialysis is currently the most commonly used renal replacement therapy. Compared with arteriovenous graft, central venous catheter, and autologous arteriovenous fistula, the possibility of postoperative re-dredging is low and there are few complications, so isometric hand exercise training is the first choice for hemodialysis strategy.
The intervention of smart technology has greatly improved the treatment effect and quality of life of patients, and it has unique advantages when applied to health care or behavior change intervention programs. This study expects to enhance hand grip strength through interactive hand exercise games combined with grip strength equipment, thereby increasing the vascular maturity of patients with postoperative autologous arteriovenous fistula, and enhancing the motivation of patients to participate.
Who can participate
Age range
20 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical diagnosis of chronic renal failure stage 4 to 5 (before dialysis) and stage 5 (patients who have started hemodialysis).
* Newly established surgical patients with autologous arteriovenous fistula.
* Aged between 20 and 70 years old.
* Having clear consciousness and being able to communicate in Chinese.
Exclusion Criteria:
* Previous dysfunction of an autologous arteriovenous fistula in the same arm.
* Injury to the fistula extremity.
* Neuromusculoskeletal abnormalities.
* Upper extremity arthritis.
* Peripheral neuropathy.
* Peripheral arterial dysfunction.
* Venous disease.
* Rheumatic disease.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Changes in vein diameter
Timeframe: The 1th week, the 4th weeks and the 8th weeks after the autologous arteriovenous fistula surgery
2
Changes in the depth of the fistula from the epidermis
Timeframe: The 1th week, the 4th weeks and the 8th weeks after the autologous arteriovenous fistula operation.
3
Changes in brachial artery blood flow rate
Timeframe: The 1th week, the 4th weeks and the 8th weeks after the autologous arteriovenous fistula operation.